Genomic predictive biomarkers to anti-HER2 targeted therapies: a combined analysis of CALGB 40601 (Alliance) and PAMELA clinical trials
      Google Scholar   
Citation:
J Clin Oncol vol 37 (15_suppl) 571-571
Meeting Instance:
ASCO 2019
Year:
2019
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Meta-Analysis
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Parents:
None
Children:
3314  
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
GSK  
Grants:
U10CA180821, U10CA180882, U24CA196171  
Corr. Author:
 
Authors:
                               
Networks:
LAPS-CT018, LAPS-NC007   
Study
CALGB-40601
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: